At a glance
ClinicalIndex Comparison RecordN/ACompleted· 177 enrolled
Drug / intervention
NobelActive Internal implant +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of NobelBiocare SFB and CFB Implants
In Brief
A clinical study evaluating NobelActive Internal implant, NobelActive External implant, and 1 other intervention for Partial Edentulism and Complete Edentulism. Completed, enrolled 177 participants.
Detailed Summary
The purpose of this study is to determine the survival rate, marginal bone resorption, soft tissue health and maintenance of the NobelActive Internal and External implants and to make comparisons with the NobelReplace Tapered Groovy implant placed in healed sites.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartial Edentulism, Complete Edentulism
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedJul 2011
Primary CompletionMay 2013
TodayJul 2026
First PostedJul 19, 2011
Enrollment StartApr 1, 2006
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 15.0 years ago
Interventions
NobelActive Internal implantdevice
Dental implant
NobelActive External implantdevice
Dental implant
NobelReplace Tapered Groovy implantdevice
Dental implant